The Lancet

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

gCentre for Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester MAHSC, St Mary's Hospital, Manchester, UK ...